Cardero Therapeutics
Sunnyvale, US
Founders & leadership
AM
Alan MaiselNamed on SEC filing
JB
Julian BucknerNamed on SEC filing
SD
Sundeep DugarNamed on SEC filing
GS
George SchreinerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$892K disclosed across 1 round · 2014
▶$892KraisedOct 2014 · 9 investors · OtherRule 506(b)
▶$892KraisedOct 2014 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Alan MaiselDirector
- Julian BucknerDirector
- Sundeep DugarExecutive Officer, Director
- George SchreinerExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $892K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cardero Therapeutics raised?
- Cardero Therapeutics has disclosed $892K raised across 1 round.
- Where is Cardero Therapeutics headquartered?
- Cardero Therapeutics is headquartered in Sunnyvale, US.